ISPE released the first report on its project concerning patient experiences with clinical trial materials. The report details the results of the Society’s patient survey, which measured the experiences of 1,425 respondents in the industry’s first large-scale effort to collect data of this kind from patients engaged in clinical trials. The report was released at the 2013 ISPE Annual Meeting, during an executive session on ISPE Research Initiatives, and it was made possible through the underwriting support of eleven companies engaged in studies involving IMPs.
The survey collected a robust set of data related to patients’ current and recent experiences, attitudes and perceptions, suggestions for improvements and demographic information. Among the survey’s key findings were:
The ISPE Patient Survey Project Team will continue to review and analyze the survey data in the coming months. The team currently plans to present additional findings throughout 2014 and to engage both industry leaders and regulators in a series of discussions to plan follow up projects. These “phase II” investigations will expand on the current data set and further investigate the themes above—as well as others which may yet be revealed.
The full report can be downloaded at www.ISPE.org/Patient-Initiative/2013NovReport ( 1 MB).
FDA Office of Pharmaceutical Quality Initiatives & 2016 Priorities
Friday, 24 Jun 2016 12.06
Interdisciplinary Perspectives on Key Pharma Industry Trends
Thursday, 23 Jun 2016 15.06
Endless Opportunities to Expand Your Knowledge & Network
Wednesday, 22 Jun 2016 12.06